Search Within

Kenneth Ho-Ming Yu

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (28)
  2. Journal Article (26)
Groups
  1. Biostatistics Service (54)
  2. Center for Pancreatic Cancer Research (54)
  3. Department of Medicine (54)
  4. Epidemiology and Biostatistics (54)
  5. Gastrointestinal Oncology Service (54)
  6. Solid Tumor Oncology Division (54)

More Groups

People
  1. Eileen O'Reilly (53)
  2. Marinela Capanu (44)
  3. David Kelsen (29)
  4. Joanne Chou (27)
  5. Anna Varghese (26)
  6. Maeve Lowery (21)

More People

Years
  1. 2024 (5)
  2. 2023 (5)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (6)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Cancer (6)
  3. Clinical Cancer Research (4)
  4. Annals of Oncology (2)
  5. Clinical Colorectal Cancer (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. Wiley Blackwell (7)
  3. American Association for Cancer Research (4)
  4. Oxford University Press (4)
  5. Elsevier Inc. (3)
  6. MDPI (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Tsui, D.; Lowery, M. A.; Capanu, M.; Yu, K. H.; Kelsen, D. P.; Gedvilaite, E.; Zhang, L.; Selcuklu, S. D.; You, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor and invasive cell gene expression profile predicts treatment response and survival in pancreatic adenocarcinoma
    Journal Article

    Yu, K. H.; Ricigliano, M.; McCarthy, B.; Chou, J. F.; Capanu, M.; Cooper, B.; Bartlett, A.; Covington, C.; Lowery, M. A.; O’Reilly, E. M.
    Cancers (2018)

    Fulltext@MSK | Save
  • Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: Challenges and recommendations
    Journal Article

    Hu, Z. I.; Shia, J.; Stadler, Z. K.; Varghese, A. M.; Capanu, M.; Salo-Mullen, E.; Lowery, M. A.; Diaz, L. A. Jr; Mandelker, D.; Yu, K. H.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma
    Journal Article

    O'Reilly, E. M.; Lee, J. W.; Lowery, M. A.; Capanu, M.; Stadler, Z. K.; Moore, M. J.; Dhani, N.; Kindler, H. L.; Estrella, H.; Maynard, H.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
    Journal Article

    Lowery, M. A.; Kelsen, D. P.; Capanu, M.; Smith, S. C.; Lee, J. W.; Stadler, Z. K.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer
    Meeting Abstract

    Park, J. J.; Hajj, C.; Reyngold, M.; Shi, W.; Zhang, Z.; Cuaron, J. J.; Crane, C. H.; O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Yu, K. H.; Cercek, A.; Hollywood, E.; Salehi, E.; Margona, E.; Bradley, M.; Witter, T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase IB trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in patients with advanced pancreatic cancer (PC)
    Meeting Abstract

    Lowery, M. A.; Harding, J. J.; Yu, K. H.; Kelsen, D. P.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics
    Meeting Abstract

    Jordan, E.; Kaley, T. J.; Capanu, M.; Estrella, H.; Leach, S. D.; Basturk, O.; Klimstra, D. S.; Allen, P. J.; Berger, M. F.; Yu, K. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Do pancreas cancer stem cells play crucial role in survival outcome?
    Meeting Abstract

    Askan, G.; Sahin, I. H.; Capanu, M.; Turkekul, M.; Yu, K. H.; Lowery, M. A.; Basturk, O.; Iacobuzio-Donahue, C.; O'Reilly, E. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save